David A. Siegel Electro Core, Inc. Transaction History

Two Sigma Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.21 - $0.36 $546 - $936	-2,600 Reduced 10.2%	22,900 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $0.68 $4,416 - $6,528	-9,600 Reduced 27.35%	25,500 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $35,532 - $80,276	-131,600 Reduced 78.94%	35,100 $18,000
Q1 2022 May 16, 2022	SELL	$0.5 - $0.88 $263,000 - $462,880	-526,000 Reduced 75.93%	166,700 $98,000
Q4 2021 Feb 14, 2022	SELL	$0.58 - $1.09 $242,555 - $455,838	-418,200 Reduced 37.65%	692,700 $403,000

Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.18 $523,218 - $663,868	562,600 Added 102.61%	1,110,900 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$1.19 - $2.06 $391,272 - $677,328	328,800 Added 149.79%	548,300 $652,000
Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $355,590 - $669,475	219,500 New	219,500 $452,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $455M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.